Both in Surgical Instruments
DexCom vs Solventum
Over the past year DXCM returned +38.9% and SOLV returned +24.5%; their daily moves had a correlation of 0.24.
DXCM +38.9% SOLV +24.5%Growth of $1, one year, split-adjusted
| Metric | DXCM | SOLV |
|---|---|---|
| Price | $83.94 | $84.80 |
| Market cap | $31.31B | $14.43B |
| Today | −0.97% | +0.06% |
| 1 month | −3.4% | −3.7% |
| 6 months | +41.1% | +22.8% |
| Year to date | +26.5% | +7.0% |
| 1 year | +44.2% | +22.8% |
| Revenue growth (YoY) | +11.2% | +2.2% |
| Gross margin | 64.3% | 58.2% |
| Net margin | 20.5% | 4.2% |
| P/E (TTM) | 31.6× | 10.1× |
| Price / sales | 6.1× | 1.7× |
| Net cash | $574.2M | -$4.88B |
| Dividend yield | — | — |
| Volatility (60d) | 29.1% | 22.6% |
| Short % of float | 4.2% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).